Litigation Details for Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. (E.D. Tex. 2015)

Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. (E.D. Tex. 2015)

Docket		Date Filed	2015-08-24
Court	District Court, E.D. Texas	Date Terminated	2017-10-16
Cause	35:271 Patent Infringement	Assigned To	William C. Bryson
Jury Demand	Both	Referred To
Parties	INNOPHARMA, INC.
Patents	8,501,174; 8,629,111; 8,633,162; 8,642,556; 8,648,048; 8,685,930; 9,248,191
Attorneys	John Wesley Samples
Firms	Schiff Hardin LLP-Chicago
Link to Docket	External link to docket

Details for Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. (E.D. Tex. 2015)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2015-08-24	1	Complaint	U.S. Patent No. 8,629,111, # 3 Exhibit 2 - U.S. Patent No. 8,633,162, # 4 Exhibit 3 - U.S. Patent No. … United States Patent Nos. 8,629,111 (“the ‘111 Patent”), 8,633,162 (“the ‘162 Patent”), 8,642,556 (“…Background A. Patents-In-Suit 1. U.S. Patent No. 8,629,111 73. On…‘556 Patent”), 8,648,048 (“the ‘048 Patent”), and 8,685,930 (“the ‘930 Patent”) under the Patent Laws…8,642,556, # 5 Exhibit 4 - U.S. Patent No. 8,648,048, # 6 Exhibit 5 - U.S. Patent No. 8,685,930)(Hill, Jack)	External link to document
2016-04-19	130	Memorandum & Opinion	several patents relating to RESTASIS— United States Patent Numbers 8,629,111 (“the ’111 patent”), 8,633,162…,162 (“the ’162 patent”), 8,642,556 (“the ’556 patent”), 8,648,048 (“the ’048 patent”), 8,685,930 (“the…“the ’930 patent”), and 9,248,191 (“the ’191 patent”). Those patents are listed in the “Orange Book,” …’930 patents. Allergan later amended its complaint to include the ’191 patent after that patent issued… I. BACKGROUND This patent infringement action arises from Abbreviated New	External link to document